Quetiapine XR monotherapy and quetiapine XR plus ongoing antidepressant versus lithium plus ongoing AD for Stage II treatment-resistant major depressive disorder

被引：0
|
作者：
Franco Martin, M. [1 ]
Figueira, M. L. [2 ]
Petrov, P. [3 ]
Rihmer, Z. [4 ]
Vavrusova, L. [5 ]
Dencker-Vansvik, E. [6 ]
Jorgensen, L. [6 ]
Koehler, J. [7 ]
Bauer, M. [8 ]
机构：
[1] Zamora Hosp, Dept Psychiat, Zamora, Spain
[2] Univ Lisbon, Dept Psychiat, P-1699 Lisbon, Portugal
[3] First Psychiat Clin, MHAT St Marina, Varna, Bulgaria
[4] Semmelweis Univ, Dept Clin & Theoret Mental Hlth, Budapest, Hungary
[5] Univ Hosp, Dept Psychiat, Postgrad Med Inst, Bratislava, Slovakia
[6] AstraZeneca, R&D, Sodertalje, Sweden
[7] AstraZeneca, Med Neurosci, Wedel, Germany
[8] Univ Klinikum Carl Gustav Carus Tech Univ, Dept Psychiat & Psychotherapy, Dresden, Germany
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2010年 / 20卷
关键词：
D O I：
10.1016/S0924-977X(10)70480-6
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S347 / S347
页数：1
相关论文
共 34 条
  • [1] Quetiapine xr monotherapy, quetiapine XR plus ongoing antidepressants and lithium plus ongoing antidepressants in patients with treatment-resistant major depressive disorder
    Bauer, M.
    DellOsso, L.
    Kasper, S.
    Pitchot, W.
    Dencker-Vansvik, E.
    Koehler, J.
    Joergensen, L.
    Montgomery, S.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 143 - 143
  • [2] QUETIAPINE XL MONOTHERAPY, QUETIAPINE XL plus ONGOING ANTIDEPRESSANTS AND LITHIUM plus ONGOING ANTIDEPRESSANTS IN PATIENTS WITH TREATMENT-RESISTANT MAJOR DEPRESSIVE DISORDER (MDD) - A UK PERSPECTIVE
    Montgomery, S.
    Bauer, M.
    Dell'Osso, L.
    Kasper, S.
    Pitchot, W.
    Dencker-Vansvik, E.
    Kohler, J.
    Jorgensen, L.
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2010, 24 : A52 - A52
  • [3] Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder
    Bauer, Michael
    Dell'Osso, Liliana
    Kasper, Siegfried
    Pitchot, William
    Vansvik, Eva Dencker
    Koehler, Juergen
    Jorgensen, Leif
    Montgomery, Stuart A.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2013, 151 (01) : 209 - 219
  • [4] Extended release Quetiapine Fumarate (Quetiapine XR) monotherapy in the treatment of patients with major depressive disorder (MDD)
    Montgomery, S.
    Cutler, A.
    Lazarus, A.
    Schollin, M.
    Brecher, M.
    [J]. EUROPEAN PSYCHIATRY, 2008, 23 : S259 - S260
  • [5] Neural Predictors of Antidepressant Treatment Response to Quetiapine XR and Citalopram in Major Depressive Disorder
    Burgess, Ashley
    White, Richard
    Cortese, Fil
    Goodyear, Bradley
    Panicker, Aaron
    Karnes, Amanda
    Roy, Kamalika
    Diwadkar, Vaibhav A.
    Ramasubbu, Raj
    [J]. BIOLOGICAL PSYCHIATRY, 2013, 73 (09) : 60S - 60S
  • [6] Quetiapine XR: Current status for the treatment of major depressive disorder
    Pae, Chi-Un
    Sohi, Manmohandeep Singh
    Seo, Ho-Jun
    Serretti, Alessandro
    Patkar, Ashwin A.
    Steffens, David C.
    Masand, Prakash S.
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2010, 34 (07): : 1165 - 1173
  • [7] Predictive factors of remission for treatment-resistant major depressive disorder (MDD) during treatment with extended-release quetiapine fumarate (quetiapine XR)
    Bauer, M.
    Kasper, S.
    Dell'Osso, L.
    Pichot, W.
    Baune, B. T.
    Koehler, J.
    Jorgensen, L.
    Dencker-Vansvik, E.
    Montgomery, S.
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2010, 14 : 20 - 21
  • [8] Efficacy of extended release quetiapine fumarate (quetiapine XR) monotherapy on sleep disturbance in patients with major depressive disorder
    Papakostas, G.
    Bandelow, B.
    Demyttenaere, K.
    Trivedi, M.
    Earley, W.
    Szamosi, J.
    Eriksson, H.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 159 - 159
  • [9] Efficacy of extended release quetiapine fumarate (quetiapine XR) monotherapy and adjunct therapy in patients with major depressive disorder
    Kalali, A.
    Montgomery, S.
    Earley, W.
    Szamosi, J.
    Eriksson, H.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 151 - 151
  • [10] Quetiapine XR monotherapy in major depressive disorder: a pooled analysis to assess the influence of baseline severity on efficacy
    Thase, Michael E.
    Montgomery, Stuart
    Papakostas, George I.
    Bauer, Michael
    Trivedi, Madhukar H.
    Svedsaeter, Henrik
    Locklear, Julie C.
    Gustafsson, Urban
    Datto, Catherine
    Eriksson, Hans
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2013, 28 (03) : 113 - 120
1234